Cannara Biotech (LOVFF) has received conditional approval to uplist its common shares to the Toronto Stock Exchange from the TSX Venture Exchange.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LOVFF:
- Cannara Biotech Posts Record Q1 2026 Results and Expands Canadian Cannabis Market Share
- Cannara Biotech reports Q1 EPS C$0.01 vs. C$0.03 last year
- Cannara Biotech Upgrades to OTCQX and Sets Dates for Q1 Results and Shareholder Meeting
- Cannara Biotech achieves OTCQX qualification
- OTC Markets welcomes Cannara Biotech to OTCQX